DRD2 and atopic eczema: While we were screening a molecular target for dermatitis using meta-analysis, we found the expression levels of dopamine receptor D2 were increased from datasets of atopic dermatitis patients (GSE6012 [23,24], and GSE120721 [25] (Figure 1A and Table S1).